88
Participants
Start Date
June 30, 2005
Study Completion Date
June 30, 2010
bleomycin sulfate
carboplatin
cisplatin
etoposide phosphate
vincristine sulfate
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham
Bristol Haematology and Oncology Centre, Bristol
Addenbrooke's Hospital, Cambridge
Gloucestershire Oncology Centre at Cheltenham General Hospital, Cheltenham
Walsgrave Hospital, Coventry
Royal Devon and Exeter Hospital, Exeter
Leeds Cancer Centre at St. James's University Hospital, Leeds
Leicester Royal Infirmary, Leicester
Saint Bartholomew's Hospital, London
University College of London Hospitals, London
Christie Hospital, Manchester
Clatterbridge Centre for Oncology, Merseyside
Nottingham City Hospital, Nottingham
Rosemere Cancer Centre at Royal Preston Hospital, Preston
Berkshire Cancer Centre at Royal Berkshire Hospital, Reading
Southampton General Hospital, Southampton
Royal Marsden - Surrey, Sutton
Beatson West of Scotland Cancer Centre, Glasgow
Raigmore Hospital, Inverness
Velindre Cancer Center at Velindre Hospital, Cardiff
Lead Sponsor
Medical Research Council
OTHER_GOV